Vistin Pharma AS avd Kragerø Fikkjebakke
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Norway
- Registered address
- Kragerø Næringspark Stuttlidalen 4, Sannidal, 3766, Norway (NOR)
- Operations here
- analysisapi manufacturemanufacture
- FDA identifiers
- FEI 3006272184 · DUNS 671330697
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-01-31
- VAIDrug Quality Assurance2019-05-24
- VAIDrug Quality Assurance2014-07-04
- VAIDrug Quality Assurance2011-06-07
Drugs this plant is listed as making
1 distinct drugs across 3 products name this site in their FDA label.
- linagliptin and metformin hydrochlorideBoehringer Ingelheim Pharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.